Back to search
EGFR mutation and copy number, EGFR protein expression and KRAS mutation as predictors of outcome with erlotinib in bronchioloalveolar cell carcinoma (BAC): Results of a prospective phase II trial
Data up to Jan 2025
Published2006
Citations43
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
No citing papers found in database